4.7 Review

P53/microRNA-34-induced metabolic regulation: new opportunities in anticancer therapy

Journal

MOLECULAR CANCER
Volume 13, Issue -, Pages -

Publisher

BMC
DOI: 10.1186/1476-4598-13-115

Keywords

LDHA; Metabolism; miR-34; MYC; p53; SIRT1

Funding

  1. National Natural Science Foundation of China [81372172]
  2. Education Department of China [212062]

Ask authors/readers for more resources

MicroRNA-34 (miR-34) is directly regulated by p53, and its potential tumor suppressive roles have been studied extensively. As a p53-induced microRNA, miR-34 functions as a tumor suppressor by playing a role in cell cycle arrest, apoptosis and metabolic regulation. Among these p53/miR-34 associated processes, apoptosis and cell cycle arrest are known as essential for p53/miR-34-mediated tumor suppression. P53-mediated metabolic processes have been shown to play pivotal roles in cancer cell biology. Recent studies have also identified several miR-34 targets involved in p53/miR-34-induced metabolic regulation. However, correlations among these metabolic targets remain to be fully elucidated. In this review, we summarize the current progress in the field of metabolic regulation by the p53/miR-34 axis and propose future directions for the development of metabolic approaches in anticancer therapy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available